SOURCE: Dynavax Technologies

Dynavax Technologies

September 01, 2011 09:00 ET

Dynavax to Present at William Blair & Company's 2011 Life Sciences Conference

BERKELEY, CA--(Marketwire - Sep 1, 2011) - Dynavax Technologies Corporation (NASDAQ: DVAX) announced today that it plans to present at William Blair & Company's 2011 Life Sciences Conference in New York on Wednesday, September 7, 2011 at 2:40 pm EDT (11:40 am PDT).

Dino Dina, M.D., Chief Executive Officer of Dynavax, will provide a corporate overview presentation. To access the live webcast and the subsequent archived recording of the presentation, please log onto Dynavax's website at

About Dynavax

Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases. The Company's lead product candidate is HEPLISAV™, a Phase 3 investigational adult hepatitis B vaccine designed to provide rapid and superior protection with fewer doses than current licensed vaccines. For more information visit

Contact Information

  • Contact:
    Shari Annes
    Investor Relations
    Email Contact